Theravance Biopharma, Inc. Reports First Quarter 2018 Financial Results and Provides Business Update

Focusing on Advancement of Highest Priority Programs DUBLIN , May 8, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (” Theravance Biopharma ” or the “Company”) (NASDAQ: TBPH) today reported financial results for the first quarter ended March 31, 2018 .

READ FULL TEXT

Leave a Reply

Your email address will not be published.